Charles C.-Y. Shih
- Molecular Medicine top 1%
- Curcumin's Biomedical Applications 3
-
- Redox biology and oxidative stress 4
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation 3
-
- T-cell and B-cell Immunology 7
- Immune Cell Function and Interaction 6
- Pharmacology top 10%
-
- Estrogen and related hormone effects 3
-
- Molecular Sensors and Ion Detection 2
-
- CAR-T cell therapy research 2
Charles C.-Y. Shih
25 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 86
- Molecular Medicine 362
- Molecular Biology 624
- Hematology 100
- Immunology 175
- Pharmacology 127
Countries citing papers authored by Charles C.-Y. Shih
This map shows the geographic impact of Charles C.-Y. Shih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles C.-Y. Shih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles C.-Y. Shih more than expected).
Fields of papers citing papers by Charles C.-Y. Shih
This network shows the impact of papers produced by Charles C.-Y. Shih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles C.-Y. Shih. The network helps show where Charles C.-Y. Shih may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles C.-Y. Shih, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 57 | |
| 2 | 2009 | 53 | |
| 3 | 2006 | 60 | |
| 4 | 2006 | 149 | |
| 5 | 2003 | 37 | |
| 6 | 2000 | 22 | |
| 7 | 1999 | 98 | |
| 8 | 1999 | 10 | |
| 9 | 1996 | 34 | |
| 10 | 1995 | 83 | |
| 11 | 1995 | 34 | |
| 12 | An S-49 cell line with a modified glucocorticoid receptor is depleted of membrane-associated glucocorticoid receptor and deficient in the lymphocytolytic response | 1994 | 7 |
| 13 | 1991 | 6 | |
| 14 | 1991 | 43 | |
| 15 | 1990 | 1 | |
| 16 | 1989 | 9 | |
| 17 | Prophylaxis of graft-vs-host disease by adoptive transfer of a class II antigen-specific murine T-cell clone. | 1987 | 5 |
| 18 | 1987 | 10 | |
| 19 | 1986 | 41 | |
| 20 | 1985 | 18 |
About Charles C.-Y. Shih
Charles C.-Y. Shih is a scholar working on Molecular Medicine, Immunology and Biophysics, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (7 papers), Immune Cell Function and Interaction (6 papers), Redox biology and oxidative stress (4 papers), Curcumin's Biomedical Applications (3 papers), Estrogen and related hormone effects (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), Molecular Sensors and Ion Detection (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Molecular Medicine (362 citations), Molecular Biology (624 citations) and Hematology (100 citations). Charles C.-Y. Shih has collaborated with scholars based in United States, Japan and Sweden. Frequent co-authors include Ching‐Yuan Su, Kuo‐Hsiung Lee, Qian Shi, Chawnshang Chang, Lin Li, Robert L. Truitt, Ann V. LeFever, Tzu-Ying Chiang, Hideji Itokawa and Hironori Ohtsu. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.